These data indicate that inhibiting PI4K reduced tumor cell autophagy and proliferation, and this strategy can be combined with MEK inhibition to enhance the tumor inhibitory effect, which is consistent with several studies showing the beneficial effect of inhibiting autophagy together with MEK inhibition when treating cancer.18,39,40. The gene discussed is MAP2K7; the disease is neoplasm.